FERMAVIR PHARMACEUTICALS, INC. - Florida Company Profile
Share on:
Share on:
| Entity Name: | FERMAVIR PHARMACEUTICALS, INC. |
| Jurisdiction: | FLORIDA |
| Filing Type: |
Domestic Profit
FERMAVIR PHARMACEUTICALS, INC. is structured as a Domestic Profit Corporation, which, in Florida signifies a Profit Corporation (also known as a C-Corporation). This business structure is recognized as a separate legal entity from its owners. This offers shareholders the benefit of limited liability protection, safeguarding their personal assets from the corporation's debts and obligations, and facilitates raising capital through the issuance of stock. In Florida, Domestic Profit Corporations are governed by Title XXXVI, Chapter 607, Florida Statutes – Florida Business Corporation Act. |
| Status: |
Inactive
The business entity is inactive. This status may signal operational issues or voluntary closure, raising concerns about the business's ability to repay loans and requiring careful risk assessment by lenders. |
| Date Filed: | 15 Nov 2002 (23 years ago) |
| Date of dissolution: | 19 Sep 2007 (18 years ago) |
| Last Event: | CORPORATE MERGER |
| Event Date Filed: | 19 Sep 2007 (18 years ago) |
| Document Number: | P02000123498 |
| FEI/EIN Number |
161639902
Federal Employer Identification (FEI) Number assigned by the IRS. |
| Address: | 420 LEXINGTON AVENUE - SUITE 445, NEW YORK, NY, 10170 |
| Mail Address: | 420 LEXINGTON AVENUE - SUITE 445, NEW YORK, NY, 10170 |
| Place of Formation: | FLORIDA |
| Name | Role | Address |
|---|---|---|
| CT CORPORATION SYSTEM | Agent | 1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL, 33324 |
| CERRONE GABRIELE | Chairman | 420 LEXINGTON AVENUE - SUITE 445, NEW YORK, NY, 10170 |
| HENSON GEOFFREY | Chief Executive Officer | 420 LEXINGTON AVENUE - SUITE 445, NEW YORK, NY, 10170 |
| HENSON GEOFFREY | Director | 420 LEXINGTON AVENUE - SUITE 445, NEW YORK, NY, 10170 |
| LARCOMBE FREDERICK | Chief Financial Officer | 420 LEXINGTON AVENUE - SUITE 445, NEW YORK, NY, 10170 |
| BRANCACCIO JOHN | Director | 420 LEXINGTON AVENUE - SUITE 445, NEW YORK, NY, 10170 |
| WHITLEY RICHARD | Director | 420 LEXINGTON AVENUE - SUITE 445, NEW YORK, NY, 10170 |
| MCGUIGAN CHRIS | Director | 420 LEXINGTON AVENUE - SUITE 445, NEW YORK, NY, 10170 |
A CIK (Central Index Key) number is a unique identifier assigned by the U.S. Securities and Exchange Commission (SEC) to companies that: Are publicly
traded on U.S. stock exchanges, File reports with the SEC.
Note: Having a CIK number indicates that: The company is registered with the SEC, Files regular financial reports (like 10-K, 10-Q), Must
comply with federal securities laws and regulations, Has public shareholders, Makes financial information publicly available through SEC's EDGAR
database.
| Event Type | Filed Date | Value | Description |
|---|---|---|---|
| MERGER | 2007-09-19 | - | CORPORATION WAS PART OF A MERGER. NON-QUALIFIED CORPORATION WAS FROST ACQUISITION CORP.. MERGER NUMBER 100000068501 |
| REINSTATEMENT | 2007-03-23 | - | - |
| ADMIN DISSOLUTION FOR ANNUAL REPORT | 2006-09-15 | - | - |
| REGISTERED AGENT ADDRESS CHANGED | 2005-12-16 | 1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL 33324 | - |
| CANCEL ADM DISS/REV | 2005-12-16 | - | - |
| CHANGE OF MAILING ADDRESS | 2005-12-16 | 420 LEXINGTON AVENUE - SUITE 445, NEW YORK, NY 10170 | - |
| REGISTERED AGENT NAME CHANGED | 2005-12-16 | CT CORPORATION SYSTEM | - |
| CHANGE OF PRINCIPAL ADDRESS | 2005-12-16 | 420 LEXINGTON AVENUE - SUITE 445, NEW YORK, NY 10170 | - |
| ADMIN DISSOLUTION FOR ANNUAL REPORT | 2005-09-16 | - | - |
| AMENDMENT AND NAME CHANGE | 2005-08-17 | FERMAVIR PHARMACEUTICALS, INC. | - |
| Name | Date |
|---|---|
| Merger | 2007-09-19 |
| REINSTATEMENT | 2007-03-23 |
| REINSTATEMENT | 2005-12-16 |
| Amendment and Name Change | 2005-08-17 |
| ANNUAL REPORT | 2004-04-20 |
| ANNUAL REPORT | 2003-04-21 |
| Domestic Profit | 2002-11-15 |
This company hasn't received any reviews.
Date of last update: 03 Jun 2025
Sources: Florida Department of State